Silicon Valley Capital Partners »

Zentalis Pharmaceuticals shares owned by Silicon Valley Capital Partners

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Silicon Valley Capital Partners from 13F filings

Historical chart of Silicon Valley Capital Partners investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Silicon Valley Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Silicon Valley Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $196 84 2.35

More positions owned by Silicon Valley Capital Partners

State Street Spdr S&p 500 Etf Etf (SPY)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard Information Technology Etf Etf (VGT)
Nvidia Corporation Stock (NVDA)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Apple Stock (AAPL)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Meta Platforms Inc Cl A Stock (META)
Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Amazon Stock (AMZN)
Broadcom Stock (AVGO)
Ishares S&p 500 Growth Etf Etf (IVW)
Advanced Micro Devices Stock (AMD)
Oracle Corp Stock (ORCL)

View all positions for Silicon Valley Capital Partners

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
Two Sigma Investments
Renaissance Technologies
Vanguard Group
Acadian Asset Management
Vanguard Capital Management
Citadel Advisors
D. E. Shaw & Co
Opaleye Management
Decheng Capital
Millennium Management
BlackRock
Bank of America Corporation
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals